Skip to content

Drug interactions

Ribociclib + Zanubrutinib

Severity: Moderate

Ribociclib and Zanubrutinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Zanubrutinib is metabolized mainly by CYP3A4, and ribociclib is a moderate CYP3A4 inhibitor. Higher zanubrutinib exposure may increase the risk of neutropenia, bleeding and infection.

What this interaction means in plain words

Ribociclib and Zanubrutinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ribociclib belongs to Oncology; Zanubrutinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Ribociclib inhibits CYP3A4, reducing zanubrutinib clearance.

What to do

Reduce zanubrutinib to 80 mg twice daily while the moderate CYP3A inhibitor is used, and monitor blood counts and bleeding. Resume the usual dose after ribociclib is stopped.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ribociclib and Zanubrutinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ribociclib with Zanubrutinib?

MediHelp rates the interaction as moderate. Ribociclib and Zanubrutinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Zanubrutinib is metabolized mainly by CYP3A4, and ribociclib is a moderate CYP3A4 inhibitor. Higher zanubrutinib exposure may increase the risk of neutropenia, bleeding and infection.

How serious is the interaction between Ribociclib and Zanubrutinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce zanubrutinib to 80 mg twice daily while the moderate CYP3A inhibitor is used, and monitor blood counts and bleeding. Resume the usual dose after ribociclib is stopped.

What other medicines interact with Ribociclib?

MediHelp also lists interactions of Ribociclib with, for example, Amiodarone, Cisapride, Dofetilide. The full list is on the Ribociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in